Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids-on-a-Chip System
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a common metabolic and progressive disease, which has emerged as a major cause of chronic liver disease worldwide. It is characterized by the process ranging from simple steatosis to nonalcoholic steatohepatitis. However, a deep understanding of NAFLD progression remains challenging due to the lack of proper in vitro human disease models. In this work, we proposed a new strategy to establish a human NAFLD model based on a human-induced pluripotent stem cell (hiPSC)-derived liver organoids-on-a-chip system. This system allows us to characterize the pathological features of NAFLD in liver organoids by exposure to free fatty acids (FFAs) in perfused three-dimensional (3D) cultures during a prolonged period. Upon FFA induction, liver organoids exhibited lipid droplet formation and triglyceride accumulation. Moreover, they showed upregulated expressions of lipid metabolism-associated genes, indicating the abnormal lipid metabolic process in NAFLD. The FFA-exposed organoids also showed reactive oxygen species (ROS) production and elevated expression of various inflammatory cytokine genes and fibrogenic markers. These alterations represented the typical biochemical characteristics of NAFLD progression, which may provide insight into the potential mechanisms underlying steatosis. The proposed human NAFLD-on-a-chip model combines stem cell organoids with organs-on-chips, which may provide a promising platform for extending their applications for disease studies and effective therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, the organoid could recapitulate several liver diseases, including fatty liver disease, cirrhosis, and monogenic metabolic diseases (Guan et al., 2017;Wang et al., 2020;Guan et al., 2021).”
From Fast formation and maturation enhancement of human liver organoids using a liver-organoid-on-a-chip (2024) · cites this paper as Wang et al., 2020
Citations
Cites
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170
Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure
Qian, X., Nguyen, H. N., Song, M. M., Hadiono, C., Ogden, S. C., Hammack, C., Yao, B., Hamersky, G. R., Jacob, F., Zhong, C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.032 · Cited by 2,127
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Research works printed but not linked: 1
- Cui W., 2010, Am. J. Transl. Res., 2, 95
Cited by
Biomedical Applications of Microfluidic Devices: A Review
Gharib, G., Bütün, İ., Muganlı, Z., Kozalak, G., Namlı, İ., Sarraf, S. S., Ahmadi, V. E., Toyran, E., van Wijnen, A. J., & Koşar, A. (2022) · Biosensors · doi:10.3390/bios12111023 · Cited by 215
Microfluidic organoids-on-a-chip: The future of human models
Saorin, G., Caligiuri, I., & Rizzolio, F. (2023) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2022.10.001 · Cited by 196
HiPSC-derived multi-organoids-on-chip system for safety assessment of antidepressant drugs
Yin, F., Zhang, X., Wang, L., Wang, Y., Zhu, Y., Li, Z., Tao, T., Chen, W., Yu, H., & Qin, J. (2021) · Lab on a Chip · doi:10.1039/d0lc00921k · Cited by 139
Human organoids-on-chips for biomedical research and applications
Wang, H., Ning, X., Zhao, F. H., Zhao, H., & Li, D. (2024) · Theranostics · doi:10.7150/thno.90492 · Cited by 158
Fernandez-Checa, J. C., Bagnaninchi, P., Ye, H., Sancho-Bru, P., Falcon-Perez, J. M., Royo, F., Garcia-Ruiz, C., Konu, O., Miranda, J., Lunov, O., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.06.021 · Cited by 126
Metadata
- Authors
- Wang, Y., Wang, H., Deng, P., Tao, T., Liu, H., Wu, S., Chen, W., & Qin, J.
- Affiliations
- Dalian Institute of Chemical Physics (CN)
- Dalian University of Technology (CN)
- Corresponding author
- Qin, Jianhua
- Venue
- ACS Biomaterials Science & Engineering
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-09-16
- Volume
- 6
- Issue
- 10
- Pages
- 5734-5743
- ISSN
- 2373-9878 (ISSN-L)
- OpenAlex
- W3087345910
- Cited by
- 109
- References
- 49
- Citations by year
- 2026: 19 · 2025: 18 · 2024: 24 · 2023: 18 · 2022: 19 · 2021: 10 · 2020: 1
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- ACS Biomaterials Science & Engineering (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology of the People's Republic of China (2018ZX09201017-001-001)
- Dalian Institute of Chemical Physics (DICP I201934)
- National Natural Science Foundation of China (31671038, 81703470, 81803492)
- Chinese Academy of Sciences (XDA16020900, XDB29050301, XDB32030200)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- non-alcoholic fatty liver disease, liver organoids, organ-on-a-chip, induced pluripotent stem cells, free fatty acids, lipid droplet formation, triglyceride accumulation, lipid metabolism, reactive oxygen species, inflammation, liver fibrosis, steatosis, disease modeling
- MeSH terms
- Humans, Organoids, Lipid Metabolism, Lab-On-A-Chip Devices, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.